News
-
FOPH: Public consultation on amendments to the International Health Regulations (IHR)
-
Decision 9C_532/2023 of 16 October 2024
-
FOPH: First «Round Table» on health cost containment
-
Decision C-5224/2022 of 18 October 2024
-
Swissmedic Journal 10/2024
-
Swissmedic: Expansion of the list of prohibited psychoactive substances to combat designer drug abuse
-
FOPH: Triennial Review of Pharmaceuticals 2024
-
Decision 2C_136/2024 of 13 September 2024
-
EMA: Global regulatory collaboration to enhance access to mpox medicinal products
-
Decision 9C_125/2022 of 10. September 2024
-
Swissmedic: Changes to the guidance documents for fast-track authorization procedure and temporary authorization for human medicinal products
-
Decision C-1080/2022 of 26 September 2024
-
FOPH: Federal Council recommends adoption of reform for standardized financing of healthcare benefits
-
Decision 9C_784/2023 of 8 October 2024
-
Swissmedic: Annual Report on Hospital Inspections 2023
-
Swissmedic Journal 09/2024
-
Swissmedic: Corrigendum to the Good Practice for the Reprocessing of Medical Devices
-
EMA: Improving efficiency of approval process for new medicinal products in the European Union
-
Swissmedic: Change of Name from «Public Summary SwissPAR» to «Summary Report on Authorisation»
-
FOPH: Federal Council decides on comprehensive revision of the Electronic Patient Dossier (EPD)
-
FOPH: Non-remuneration and anti-discrimination measures for blood donations effective from 2025